510(k) Report

510(k) · Cleared

Cleared

Depuy LPS Proximal Tibial Component

K062301510(k) SpecialCleared Oct 13, 200666-day reviewClass II21 CFR 888.3510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DePuy Orthopaedics, Inc. · KRO Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/Polymer

Cleared on Oct 13, 2006 as substantially equivalent to K011810 (Depuy, Inc., 2001) and 1 other predicate after a 66-day review. Its family tree reaches back 3 generations to 1987.

Decided
Oct 13, 2006
Review
66 days
Class
Class II
Product code
KRO
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K870730 (1987). 12 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestor2002: 1 other ancestor1991: 1 other ancestor1990: 1 other ancestor1998: 1 other ancestor1997: 2 other ancestors1994: 1 other ancestor1993: 1 other ancestorK870730 · Noiles Total Knee Prosthesis · Joint Medical Products Corp. · 1987K003182 · Orthogenesis LPS System · Depuy, Inc. · 2001K033959 · LPS · Depuy, Inc. · 200419851990199520002005
Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 3 other ancestors3 generations back: 5 other ancestors K033959 · LPS · Depuy, Inc. · 2004K003182 · Orthogenesis LPS System · Depuy, Inc. · 2001K870730 · Noiles Total Knee Prosthesis · Joint Medical Products Corp. · 19870
  1. Root · 3 generations backK870730 Noiles Total Knee ProsthesisJoint Medical Products Corp. · 1987
  2. 2 generations backK003182 Orthogenesis LPS SystemDepuy, Inc. · 2001
  3. 1 generation backK033959 LPSDepuy, Inc. · 2004
  4. This deviceK062301 Depuy LPS Proximal Tibial ComponentDePuy Orthopaedics, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K870730Noiles Total Knee ProsthesisJoint Medical Products Corp.1987—
−2K003182Orthogenesis LPS SystemDepuy, Inc.2001—
−1K033959LPSDepuy, Inc.2004—
0 (this device)K062301Depuy LPS Proximal Tibial ComponentDePuy Orthopaedics, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199110
199310
199410
199720
199810
200110
200210
FIG. 1 — Lineage of K062301, 1987–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KRO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KRO device

  1. #1 K251665 Triathlon® Hinge Knee Systemscore 19.0 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K011810Orthogenesis LPS Proximal Tibial Replacement and Orthogenesis LPS Tibial BearingDepuy, Inc.2001—
*K033959LPS
Summary page 1
…VICES: DePuy Orthogenesis LPS Proximal Tibial Replacement System (KOI 1810) DePuy LPS (K033959) DEVICE DESCRIPTION: The DePuy LPS Proximal Tibial Component is a modular component that is designed to replace the proximal p…
Depuy, Inc.2004—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 3.0 years on median.
  • 2 of the 12 ancestors have a recall of any class.

How does its category compare?

All KRO devices

KRO Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KRO

3in 2025

2007: 12008: 32009: 32010: 12011: 22012: 22013: 32014: 22015: 62016: 32017: 12019: 32020: 12021: 32022: 12023: 42024: 32025: 32026 (partial year): 1
2007high 6 (2015) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRO

56in 2025

2008: 126 days median2009: 86 days median2013: 189 days median2015: 113 days median2016: 148 days median2019: 244 days median2021: 57 days median2023: 148 days median2024: 87 days median2025: 56 days median
2007high 244 (2019) · low 56 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KRO

14so far in 2026, the most since 2007

2007: 12008: 32009: 82011: 12012: 12013: 22015: 12016: 52017: 42018: 12021: 12025: 12026 (partial year): 14
2007high 14 (2026) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KRO

915in 2025

2007: 372008: 442009: 662010: 1102011: 1192012: 1732013: 1942014: 4062015: 3332016: 3692017: 5432018: 6142019: 7592020: 7492021: 7702022: 8922023: 7462024: 8552025: 915
2007high 915 (2025) · low 37 (2007)2025

MAUDE reports naming product code KRO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—137
20083126344
2009386866
20101—0110
20112—1119
20122—1173
201331892194
20142—0406
201561131333
201631485369
20171—4543
20180—1614
201932440759
20201—0749
20213571770
20221—0892
202341480746
20243870855
20253561915
20261—14—

What is it indicated for?

The DePuy LPS is intended for use in replacement of the mid-shaft portion of the femur, proximal, distal and/or total femur, and proximal tibia, especially in cases that require extensive resection and replacement. Specific diagnostic indications for use include: malignant tumors (e.g., osteosarcomas, chondrosarcomas, giant cell tumors, bone tumors) requiring extensive resection and replacement; patient conditions of noninflammatory degenerative joint…

Read the full statement (144 words)

The DePuy LPS is intended for use in replacement of the mid-shaft portion of the femur, proximal, distal and/or total femur, and proximal tibia, especially in cases that require extensive resection and replacement. Specific diagnostic indications for use include:

malignant tumors (e.g., osteosarcomas, chondrosarcomas, giant cell tumors, bone tumors) requiring extensive resection and replacement;

patient conditions of noninflammatory degenerative joint disease (NIDJD), e.g. avascular necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis, requiring extensive resection and replacement;

revision cases for a failed previous prosthesis requiring extensive resection and replacement;

severe trauma requiring extensive resection and replacement.

The LPS is also intended for use in bone loss post-infection, where the surgeon has elected to excise the bone and replacement is required.

The distal femoral component, the S-ROM Tibial Tray and the non-porous coated straight and bowed stems are intended for cemented use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062301: Depuy LPS Proximal Tibial Component.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K062301

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026